|  | 
| MechanismBCL2 gene modulators [+1]  | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePending | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with Novation Pharmaceuticals, Inc.
0  Patents (Medical) associated with Novation Pharmaceuticals, Inc.
100 Deals associated with Novation Pharmaceuticals, Inc.
100 Translational Medicine associated with Novation Pharmaceuticals, Inc.